Indication for myocardial biopsy in myocarditis and dilated cardiomyopathy;Indikation der herzmuskelbiopsie bei myokarditis und dilatativer kardiomyopathie

Medizinische Klinik

Volumn 100, Issue 9, 2005, Pages 553-561

  Kuhn, Horst ^b   Lawrenz, Thorsten ^c   Beer, Gerald ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b OWL University   (Germany)

^c NONE

Author keywords

Dilated cardiomyopathy; Myocardial biopsy; Myocarditis; Sarcoid heart disease

Indexed keywords

CLINICAL EXAMINATION; CLINICAL PRACTICE; CONGESTIVE CARDIOMYOPATHY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; EARLY DIAGNOSIS; GERMANY; HEART CATHETERIZATION; HEART MUSCLE BIOPSY; HEART VENTRICLE FUNCTION; HUMAN; IMMUNOHISTOCHEMISTRY; MOLECULAR BIOLOGY; MYOCARDIAL DISEASE; MYOCARDITIS; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; SAMPLE; SARCOIDOSIS; VALIDATION PROCESS; VIRUS EXAMINATION; VIRUS MYOCARDITIS; WORLD HEALTH ORGANIZATION;

ACUTE DISEASE; ADULT; AGED; BIOPSY; CARDIOMYOPATHIES; CARDIOMYOPATHY, DILATED; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; HUMANS; MALE; MYOCARDITIS; MYOCARDIUM; OBSERVER VARIATION; PROGNOSIS; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY;

EID: 25444517307     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-005-1076-3     Document Type: Review

References (81)

1. Anastasiou-Nana MI, O'Connel JB, Nanas JN, et al. Relative efficiency and risk of endomyocardial biopsy: comparison in heart transplant and non transplant patients. Cathet Cardiovasc Diagn 1989;18: 7-11.
2. Arbustini E, Repetto A, Pasotti M, et al. Cardiomyology: an attempt to link structural cardiac and skeletal muscle damage in patients with dilated cardiomyopathy. 2004; Eur Heart J 2004; Suppl F, 6:F40-F53.
3. Aretz HT, Billingham ME, Edwards WD, et al. Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol 1986;1:3-14.
4. Bargout R, Kelly RF. Sarcoid heart disease: clinical course and treatment. Int J Cardiol 2004;97:173-82.
5. Beer G, Frenzel H, Hort W, et al. Clinical value of endomyocardial biopsy: a prospective blinded study in patients with various myocardial disorders. Eur Heart J 2004; Suppl 11:410.
6. Beer G, Reinecke P, Gabbert HE, et al. Fabry disease in patients with hypertrophic cardiomyopathy (HCM). Z Kardiol 2002;91:992-1002.
7. Beer G, Strunk-Müller C. Diagnose einer Borderline-Myokarditis anhand der Dallas-Kriterien - ein Problem weiter bestehender klinischer und pathologischer Konfusion. Z Kardiol 2004;93:377.
8. Bollinger O. Über die Häufigkeit und Ursachen der idiopathischen Herzhypertrophie in München. Dtsch Med Wochenschr 1884;10:180.
9. Breithardt G, Kuhn H, Hammel D, et al. Cardiac resynchronization therapy into the next decade: from the past to morbidity/mortality trials. Eur Heart J 2002;4:Suppl D:102-10.
10. Burns JC, Glodé MP. Kawasaki syndrome. Lancet 2004;364:533-44.
11. Chander S, Talwar KK, Chopra B. Immunohistochemical characterisation and quantitative evaluation of lymphomononuclear cells in dilated cardiomyopathy - an endomyocardial biopsy study. Indian Heart J 1995;47:360-4.
12. Chow LH, Radio SJ, Sears TD, et al. Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myokarditis. J Am Coll Cardiol 1989; 14:915-20.
13. Cooper LT, Berry GJ, Shabetai R. Idiopathic giant-cell myocarditis - natural history and treatment. N Engl J Med 1997;336:1860-6.
14. Cowley CG, Lozier JS, Orsmond GS, et al. Safety of endomyocardial biopsy in children. Cardiol Young 2003;13:404-7.
15. D'Ambrosio A, Patti G, Manzoli A, et al. The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 2001;85:499-504.
16. Devaux B, Scholz D, Hirche A, et al. Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure. Eur Heart J 2001;18:470-9.
17. Doerr W. Morphologie der Myokarditis. Verh Dtsch Ges Inn Med 1971;77:301-35.
18. Elliott P. Diagnosis and management of dilated cardiomyopathy. Heart 2000;84:106-12.
19. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000;343:1388-98.
20. Figulla HR. Transformation of myocarditis and inflammatory cardiomyopathy to idiopathic dilated cardiomyopathy: facts and fiction. Med Microbiol Immunol 2004;193:61-4.
21. Figulla HR, Stille-Siegener M, Mall G, et al. Myocardial enterovirus infection with left ventricular dysfunction: a benign disease compared with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1995;25:1170-5.
22. Franz WM, Müller M, Müller OJ, et al. Association of nonsense mutation of dystrophin gene with disruption of sarcoglycan complex in X-linked dilated cardiomyopathy. Lancet 2000;355:1781-5.
23. Frenzel H, Kasper M, Kuhn H, et al. Light and electron microscopy findings in early and late stages of heart failure. Studies of endomyocardial biopsies of patients with latent and dilated cardiomyopathy. Z Kardiol 1985;74:135-43.
24. Frenzel H, Schwartzkopf, Kuhn H, et al. Cardiac amyloid deposits in endomyocardial biopsies. Light microscopic, ultrastructural, and immunohistochemical studies. Am J Clin Pathol 1986;85:674-80.
25. Frenzel H, Schwartzkopff B, Wagner E, et al. Zellinfiltration und Fibrose im Myokard bei unterschiedlichen Herzerkrankungen. Z Kardiol 1988;77:Suppl 1:35.
26. Frustaci A, Chimenti C, Pieroni M. Prognostic significance of left ventricular aneurysms with normal global function caused by myocarditis. Chest 2000;118:1696-702.
27. Fuchs M, Drexler H. Entzündliche Mechanismen bei Herzinsuffizienz. Herz 2004;29:782-7.
28. Grogan M, Redfield M, Baily KR, et al. Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1995;26:80-4.
29. Grunig E, Tasman JA, Kucherer H, et al. Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol 1998;31:186-94.
30. Hauck AJ, Kearney DL, Edwards WD. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc 1989;64:1235-45.
31. Hort W. Dilatative Kardiomyopathie (DCM). Morphologie und Ätiologie. Myokarditis und DCM. In: Hort W, Hrsg. Pathologische Anatomie des Herzens und seiner Hüllen, Pathologie des Endokard, der Kranzarterien und des Myokard, Bd 2. Berlin-Heidelberg: Springer, 2000:929-1053.
32. Hufnagel G, Pankuweit S, Richter A, et al. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESECID). Herz 2000;25:279-85.
33. Keeling PJ, Jeffery S, Kaforio ALP, et al. Similar prevalence of enteroviral genome within the myocardium from patients with idiopathic dilated cardioymopathy and controls by the polymerase chain reaction. Br Heart J 1992;68:554-9.
34. Klein RM, Jiang H, Niederacher D, et al. Frequency and quantity of the parvovirus B 19 genome in endomyocardial biopsies from patients with suspected myocarditis or idiopathic left ventricular dysfunction. Z Kardiol 2004;93:300-9.
35. Kühl U, Pauschinger M, Noutsias M, et al. Diagnosis and treatment of patients with virus induced inflammatory cardiomyopathy. Eur Heart J 2002;4: Suppl I:173-80.
36. Kuhn H. Epidemiologie, Verlaufsformen und Prognose der dilatativen Kardiomyopathie (DCM). Z Herz Thorax Gefäßchir 1991;5:1-11.
37. Kuhn H, Beer G, Gietzen F. Definition and classification of cardiomyopathies [Correspondence]. Circulation 1996;94:2991-2.
38. Kuhn H, Breithardt G, Knieriem HJ, et al. Endomyocardial catheter biopsy in heart disease of unknown etiology. In: Kaltenbach M, Loogen F, Olsen EGJ, eds. Cardiomyopathy and myocardial biopsy. Berlin-Heidelberg-New York: Springer, 1978:121-37.
39. Kuhn H, Gietzen F, Beer G. Kardiomyopathien. In: Classen M, Dierkesmann R, Heimpel H, et al., Hrsg. Rationelle Diagnostik und Therapie in der Inneren Medizin, Leitlinien. München: Urban & Fischer, 2004:13D.
40. Kuhn H, Gietzen F, Beer G, et al. Epidemiology of idiopathic dilated cardiomyopathy. In: Figulla H, et al., eds. Idiopathic dilated cardiomyopathy. Berlin-Heidelberg: Springer, 1993:13-25.
41. Kuhn H, Lawrenz T, Beer G. Herzmuskelerkrankungen, Perikarderkrankungen. In: Vallbracht A, Kaltenbach M, Hrsg. Herz- und Gefaßkrankheiten Kompakt. Stuttgart: Thieme, 2005:im Druck.
42. Lie JT. Myocarditis and endomyocardial biopsy in unexplained heart failure: a diagnosis in search of a disease. Ann Intern Med 1988;109:525-8.
43. Lie JT. Myocarditis and endomyocardial biopsy. Ann Intern Med 1989;110:165-6.
44. Lozano MD. Myovascular coronary arterial vasculopathy - predictive value of endomyocardial biopsy. Z Kardiol 2000;89:Suppl IX:54-7.
45. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis. A comparison to histology and molecular pathology. Circulation 2004;109:1250-8.
46. Maisch B. Myokardbiopsien und Perikardioskopien. In: Hess OM, Simon RW, Hrsg. Herzkatheter, Einsatz in Diagnostik und Therapie. Berlin-Heidelberg-New York: Springer, 1999:303-49.
47. Maisch B, Bültmann B, Factor S, et al. Dilated cardiomyopathy with inflammation or chronic myocarditis - variability and consensus in diagnosis. Eur Heart J 1998;19:647.abstract.
48. Maisch B, Funcker R, Alter P, et al. Dilatative Kardiomyopathie und Myokardids. Aktuelle diagnostische Erfordernisse und therapeutische Möglichkeiten. Internist (Berl) 2002;43:45-65.
49. Maisch B, Herzum M, Schönian U. Pathogenesis of disease: humans. In: Banatvala JE, ed. Viral infections of the heart. 2000:139-75.
50. Maisch B, Hufnagel G, Kölsch S, et al. Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins. Herz 2004;29:624-36.
51. Mason JW. Inflammation and myocarditis. In: Feuerstein GZ, Libby P, Mann DL, eds. Inflammation and cardiac disease. Basel: Birkhauser, 2003:315-24.
52. Mason JW. Myocarditis and dilated cardiomyopathy. Cardiovasc Res 2003;60:5-10.
53. Mason JW, O'Connel JB, Hershkowitz A, et al. A clinical trial of immunosuppressive therapy. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995;333:269-75.
54. McCarthy RE, Boehmer JP, Hruban RH, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000;342:690-5.
55. McNamara DM, Holubkov R, Starling RC, et al. Controlled trial of intravenous immune globuline in recent-onset dilated cardiomyopathy. Circulation 2001;103:2254-9.
56. Münzinger W. Das Tübinger Herz. Ein Beitrag zur Lehre von der Überanstrengung des Herzens. Arch Klin Med 1877;19:449-70.
57. Nieminen MS, Böhm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. Eur Heart J 2005;26:384-416.
58. Noutsias M, Noutsias E, Kühl U, et al. Meta-Analyse über den immunhistologischen und histologischen Nachweis einer intramyokardialen Entzündung bei Myokarditis und dilatativer Kardiomyopathie. Z Kardiol 2004;93:377.
59. Noutsias M, Pauschinger M, Schultheiss HP, et al. Advances in the immunhistological diagnosis of inflammatory cardiomyopathy. Eur Heart J 2002;4: Suppl I:I54-62.
60. Osterziel K. Genetik der dilatativen Kardiomyopathie. Z Kardiol 2001;90:461-9.
61. Pankuweit S, Ruppert V, Maisch B. Inflammation in dilated cardiomyopathy. Herz 2004;29:788-93.
62. Parillo JE. Inflammatory cardiomyopathy (myocarditis). Which patients should be treated with anti-inflammatory therapy? Circulation 2001;104:4-6.
63. Pauschinger M, Noutsias M, Kühl U, et al. Antivirale Therapie bei viraler Herzerkrankung. Herz 2004;29:618-23.
64. Peters NS, Poole-Wilson PA. Myocarditis - continuing clinical and pathologic confusion. Am Heart J 1991;121:942-7.
65. Rauchhaus M, Müller-Werdan U. Zytokine bei Herzerkrankungen. Internist (Berl) 2001;42:75-84.
66. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Tasc Force on the Definition and Classification of Cardiomyopathies. Circulation 1996;93:841-2.
67. Schultheiss HP. Dilated cardiomyopathy - a chronic myocarditis? New aspects on diagnosis and therapy. Z Kardiol 1993;82:Suppl 4:425-32.
68. Senac JB. Traité de la structure du cœur, de son action et de ses maladies 1772. In: Schramm P. Editio rarissima, 1986 (zitiert in [49]).
69. Shanes JG, Ghali J, Billingham ME et al. Interobserver variability in the pathologic interpretation of endomyocardial biopsy result. Circulation 1987;75:401.
70. Sharma OP. Diagnosis of cardiac sarcoidosis. Chest 2003;123:19.
71. Shields RC, Tazelaar HD, Berry GJ, et al. The role of right ventricular endomyocardial biopsy for idiopathic giant cell myocarditis. J Card Fail 2002;8:74-8.
72. Strauer BE, Kandolf R, Mall G, et al. Update 2001: Myokarditis - Kardiomyopathie. Med Klin 2001;96:608-25.
73. Syed J, Myers R. Sarcoid heart disease. Can J Cardiol 2004;20:89-93.
74. Terasaki F, Okabe M, Hayashi T, et al. Myocardial inflammatory cell infiltrates in cases of dilated cardiomyopathy: light microscopic, immunohistochemical, and virological analyses of myocardium specimens obtained by partial left ventriculectomy. J Card Surg 1999;14:141-6.
75. Thiene G, Corrado D, Basso C. Cardiomyopathies: is it time for a molecular classification? Eur Heart J 2004;25:1772-5.
76. Thorneby A, Delborg M. Perimyocarditis - a diagnostic dilemma with good prognosis. Lakartidningen 2000;97:1818-21.
77. Uemura A, Morimoto S, Hiramitsu S, et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of cardiac biopsies. Am Heart J 1999;138:299-302.
78. Vignaux O. Cardiac sarcoidosis: spectrum of MRI features. AJR Am J Roentgenol 2005;184:249-54.
79. Weiss LM, Liu XF, Chang KL, et al. Detection of enteroviral RNA in idiopathic dilated cardiomyopathy and other human cardiac tissues. J Clin Invest 1992;90:156-9.
80. Wichter T, Paul M, Eckardt L, et al. Arrhythmien aus dem rechten Ventrikel. Internist (Berl) 2004;45:1125-35.
81. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy. Two-year follow-up results. Circulation 2001;104:39-45.